-

Majority of Plan Sponsors Considering Buyouts of Retiree Life, Medical Obligations

Nearly nine in ten plan sponsors considering the transfer of all or some of these liabilities to insurers, according to MetLife’s 2023 Post Retirement Benefits Poll

NEW YORK--(BUSINESS WIRE)--In the coming years, a significant majority of plan sponsors are considering transferring some or all of their retiree medical and retiree life insurance obligations to an insurance company. Eighty-eight percent of plan sponsors reported that they are considering a retiree medical buyout and 84% note they are considering a retiree life buyout, according to MetLife’s inaugural Post Retirement Benefits Poll.

“Retiree life and medical benefits are promises that retirees and their families count on. Given the long-term nature of these liabilities, plan sponsors are exposed to investment risk, interest rate risk and mortality or longevity risk, which create challenges around managing these liabilities.” said Jay Wang, senior vice president and head of Risk Solutions for MetLife’s Retirement & Income Solutions (RIS). “For plan sponsors, these risk transfer solutions help to mitigate volatility on their corporate balance sheets. For retirees, it improves security of these promises by shifting these obligations to an insurer with deep expertise and long history of managing these risks.”

The Role of Post Retirement Benefits

Traditionally, post retirement benefit offerings, including pensions, retiree life and retiree medical, have played a critical role in attracting and retaining employees. Today, besides the pension benefits, many companies still have open retiree life and retiree medical plans. The Poll found 86% of companies report having open retiree medical insurance plans and the same percentage (86%) report their retiree life insurance plans are still open.

“Due to the nature of these offerings, they accumulate liabilities over many years and their promises extend well into the future,” said Charlie DeClara, assistant vice president and head of RIS Post Retirement Benefits. “Because of this, plan sponsors have been exploring strategies to fund or transfer obligations associated with these benefits and to address the financial impact of their volatility.”

More than eight in ten plan sponsors (85%) report that their company’s post retirement benefits receive significant attention from corporate management because of financial effects on their corporate balance sheet and income statement.

Post Retirement Funding and Buyout Solutions

The Poll found that most of the plan sponsors surveyed were familiar with the concepts of funding or transferring some or all obligations through a retiree medical buyout (89%) or retiree life insurance buyout (89%).

According to the plan sponsors surveyed, the most important benefit of a retiree medical buyout is lifetime security for retirees’ healthcare benefits (71%). Half of plan sponsors cited improving benefit security for retirees as an important factor for retiree life insurance buyouts.

SECURE 2.0 and the Future of Post Retirement Funding and Buyout Solutions

An important consideration when looking at a retiree medical or retiree life insurance buyout is the funded status of the obligations. Having a well-funded plan allows plan sponsors to develop long-term solutions to a buyout or to transfer these obligations to an insurance company, which would settle or remove these liabilities from the corporate balance sheet.

The COVID Tax Relief Acts of 2020 and 2021 took a significant step in helping plan sponsors improve the funding of these obligations. As a result of this legislation and under Internal Revenue Code 420, plan sponsors have the ability to transfer excess pension assets from an overfunded defined benefit (DB) plan to fund retiree medical/retiree life insurance obligations. In late 2022, the SECURE 2.0 Act was passed extending this provision, delaying its sunset from the end of 2025 to 2032.

“SECURE 2.0 ensured plan sponsors have extended access to a valuable tool to help them manage the funding levels of their retiree life and retiree medical liabilities,” said DeClara, assistant vice president and head of RIS Post Retirement Benefits. “By making the requirements for transferring excess pension assets to fund these obligations less burdensome, plan sponsors can take an important first step on the road to a potential buyout.”

Plan sponsors recognize the importance of this legislation. At the time of the survey, most plan sponsors (87%) had been closely following SECURE 2.0 and related legislation, and 84% believe it was important for SECURE 2.0 to extend this provision.

About the Study

The MetLife 2023 Post Retirement Benefits Poll was fielded between November 1 and November 16, 2022. MetLife commissioned MMR Research Associates, Inc. to conduct the online survey. Survey responses were received from 250 DB plan sponsors in human resources/benefits, treasury, and finance whose organizations have one or more post retirement medical plans and/or post retirement life insurance plans for current or former employees.

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Contacts

MetLife Contact:
Judi Mahaney
jmahaney@metlife.com
212-578-7977

MetLife, Inc.

NYSE:MET

Release Versions

Contacts

MetLife Contact:
Judi Mahaney
jmahaney@metlife.com
212-578-7977

More News From MetLife, Inc.

MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (“Potemkin”) to purchase up to 100,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.02 percent of MetLife shares of common stock outstanding as of March 31, 2026. Potemkin’s offer price of $44.20 per share is approximately 41.35 percent lower than the $75.36 closing price of MetLife common sto...

MetLife Investment Management Originates $26 Billion in Private Fixed Income Transactions in 2025

WHIPPANY, N.J.--(BUSINESS WIRE)--MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced that it originated approximately $26 billion in private fixed income transactions for clients in 2025, increasing total assets under management on MIM’s private fixed income platform to $144.7 billion as of December 31, 2025.1 MIM’s private fixed income platform comprises private corporate and infrastructure debt, private asset-based fin...

MetLife to Announce First Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) will release its first quarter 2026 financial results on Wednesday, May 6, 2026, after the market closes. The earnings news release, financial supplement and related materials will be posted on MetLife’s Investor Relations webpage at investor.metlife.com. MetLife will hold its first quarter 2026 earnings conference call on Thursday, May 7, 2026, from 9-10 a.m. (ET) via a live webcast. Please click on the following link to register: https://ev...
Back to Newsroom